US11565996B2ActiveUtilityA1

Compounds for use as inhibitors of alternative oxidase or cytochrome bc1 complex

Assignee: ALTERNOX SCIENT LIMITEDPriority: Apr 25, 2012Filed: Sep 30, 2020Granted: Jan 31, 2023
Est. expiryApr 25, 2032(~5.8 yrs left)· nominal 20-yr term from priority
C07C 43/1787A01N 63/50A61K 31/085A61K 31/277C07C 69/18C07C 235/60A61K 31/11A01N 35/04C07C 39/373C07C 255/53C07C 69/157A01N 49/00C07C 49/835A61K 31/222A01N 31/16A01N 37/24A01N 37/02C07C 39/245C07C 69/84A61K 31/055C07C 65/28A01N 37/40C07C 47/565C07C 69/21A01N 37/44Y02A50/30A61K 31/12A01N 37/34C07C 69/63C07C 43/23A61K 31/166A01N 37/18C07C 235/42A61K 31/341A61P 31/04Y10S424/10A61K 31/192A61P 33/00C07C 39/24A61P 1/00C07C 43/178A61P 31/10A61P 27/02A61K 31/075A61K 31/122A61P 31/02C07C 47/55C07C 43/166A61P 33/02A61P 31/00A61P 43/00C07D 307/32A01N 63/30A01N 37/10A01N 43/08A61K 31/235
54
PatentIndex Score
0
Cited by
29
References
13
Claims

Abstract

The invention provides compounds for use in inhibiting a microbial alternative oxidase (AOX) and/or cytochrome bc 1 complex. The invention extends to the use of such inhibitors in agrochemicals and in pharmaceuticals, for treating microbial infections, including fungal infections.

Claims

exact text as granted — not AI-modified
The invention claimed is: 
     
       1. A method of treating a fungal infection in a subject, the method comprising administering to a subject in need of such treatment a therapeutically effective amount of the compound of formula I: 
       
         
           
           
               
               
           
         
         wherein R 1  is a group selected from: CHO; CN; C(O)NH 2 ; C(O)NHCH 3 ; C(O)CH 3 ; COOH; and COOCH 3 ; 
         R 2  is hydrogen, hydroxyl or an alkoxy group with 1 to 3 C atoms; 
         R 3  is a straight chain or branched alkyl or alkylene with 4 to 20 C atoms, that is optionally mono- or polysubstituted by a C 1  to C 4  alkyl group; 
         R 4  is a hydroxyl group; 
         R 5  is a halogen group; and 
         R 6  is H or a C 1  to C 4  alkyl group, 
         wherein the fungal infection is caused by a fungus comprising an alternative oxidase (AOX). 
       
     
     
       2. The method according to  claim 1 , wherein R 2  is a hydroxyl group. 
     
     
       3. The method according to  claim 1 , wherein R 3  is a straight chain or branched alkyl or alkylene with 6 to 15 C atoms, 8 to 12 C atoms or 8 to 10 C atoms, that is optionally mono- or polysubstituted by a C1 to C4 alkyl group. 
     
     
       4. The method according to  claim 1 , wherein R 3  is a diene having 6 to 15 C atoms that is substituted with at least one methyl group. 
     
     
       5. The method according to  claim 1 , wherein R 5  is a chlorine, bromine, fluorine or iodine group. 
     
     
       6. The method according  claim 1 , wherein R 5  is a chlorine group; or wherein R6 is a methyl, ethyl or propyl group. 
     
     
       7. The method according  claim 1 , wherein:
 R 1  is selected from CHO; CN; C(O)NH 2 ; C(O)NHCH 3 ; C(O)CH 3 ; COOH; and COOCH 3 ; 
 R 2  is a hydroxyl group; 
 R 3  is a straight chain or branched alkyl or alkylene with 4 to 20 C atoms, that is optionally mono- or polysubstituted by a C 1  to C 4  alkyl group; 
 R 4  is a hydroxyl group; 
 R 5  is a chlorine atom; and 
 R 6  is H or a C 1  to C 4  alkyl group. 
 
     
     
       8. The method according to  claim 1 , wherein:
 R 1  is selected from CHO; CN; C(O)NH 2 ; C(O)NHCH 3 ; C(O)CH 3 ; COOH; and COOCH 3 ; 
 R 2  is a hydroxyl group; 
 R 3  is a straight chain or branched alkyl or alkylene with 6 to 15 C atoms, that is optionally mono- or polysubstituted by a C 1  to C 2  alkyl group; 
 R 4  is a hydroxyl group; 
 R 5  is a chlorine atom; and 
 R 6  is H or a C 1  to C 4  alkyl group. 
 
     
     
       9. The method according to  claim 1 , wherein:
 R 1  is selected from CHO; CN; C(O)NH 2 ; C(O)NHCH 3 ; C(O)CH 3 ; COOH; and COOCH 3 ; 
 R 2  is a hydroxyl group; 
 R 3  is an alkylene chain having 8 to 10 C atoms, and is substituted with at least one methyl group; 
 R 4  is a hydroxyl group; 
 R 5  is a chlorine atom; and 
 R 6  is a methyl group. 
 
     
     
       10. The method of  claim 1 , wherein the subject is human. 
     
     
       11. The method of  claim 1 , wherein the fungus is selected from a group of genera consisting of  Aspergillus; Blumeria; Candida; Cryptococcus; Encephalitozoon; Fusarium; Leptosphaeria; Magnaporthe; Phytophthora; Plasmopara; Pneumocystis; Pyricularia; Pythium; Puccinia; Rhizoctonia; Trichophyton ; and  Ustilago.    
     
     
       12. The method of  claim 11 , wherein the fungus is selected from a group of species consisting of  Aspergillus flavus; Aspergillus fumigatus; Aspergillus nidulans; Aspergillus niger; Aspergillus parasiticus; Aspergillus terreus; Blumeria graminis; Candida albicans; Candida cruzei; Candida glabrata; Candida parapsilosis; Candida tropicalis; Cryptococcus neoformans; Encephalitozoon cuniculi; Fusarium solani; Leptosphaerianodorum; Magnaporthe grisea; Phytophthora capsici; Phytophthora infestans; Plasmopara viticola; Pneumocystis jiroveci; Puccinia coronata; Puccinia graminis; Pyricularia oryzae; Pythium ultimum; Rhizoctonia solani; Trichophytoninterdigitale; Trichophyton rubrum ; and  Ustilago maydis.    
     
     
       13. The method of  claim 1 , wherein the fungus is  Saccharomyces  spp.,  S. cerevisiae; Candida  spp., or  C. albicans.

Join the waitlist — get patent alerts

Track US11565996B2 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.